Effects of Exogenous Leptin on Satiety and Satiation in Patients with Lipodystrophy and Leptin Insufficiency
Open accessAbstract
To examine leptin’s role in human appetite regulation, we studied recombinant methionyl human leptin’s effects on satiation and satiety in a model of leptin insufficiency, lipodystrophy. Eight females with hypoleptinemia and lipodystrophy were given sc injections of A-100 (maximal dose, 200% of that predicted to normalize serum leptin) for 4 months. Satiation and satiety were determined before and again during leptin treatment. Satiation was measured as the time to voluntary cessation of eating from a standardized food array after a 12-h fast. Satiety was determined as the time to hunger sufficient to consume a full meal after consumption of a standardized preload. During leptin treatment, satiation time decreased (41.2 ± 18.2 to 19.5 ± 10.6 min; P = 0.01), satiety time increased (62.9 ± 64.8 to 137.8 ± 91.6 min; P = 0.04), energy consumed to produce satiation decreased (2034 ± 405 to 1135 ± 432 kcal or 8.5 ± 1.7 to 4.7 ± 1.8 MJ; P < 0.01), and the amount of food desired in the postabsorptive state decreased (P < 0.02). Ghrelin concentrations also decreased during leptin administration (284.3 ± 127.9 to 140.6 ± 104.5 pmol/liter; P < 0.002). We conclude that increased leptin in patients with lipodystrophy results in less caloric, shorter, more satiating meals and longer-lived satiety. These data support the hypothesis that leptin plays an important, permissive role in human appetite regulation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
When patients with lipodystrophy and reduced leptin were placed on r-metHuLeptin, they reported improved satiety and satiation, resulting in approximately 40% reduction of caloric intake.
“When patients with lipodystrophy and reduced leptin were placed on r-metHuLeptin, they reported improved satiety and satiation, resulting in ϳ40% reduction of caloric intake (22).”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829 · see citing works
Weight-Reducing Effects of the Plasma Protein Encoded by the <i>obese</i> Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451 · see citing works
Effects of the <i>obese</i> Gene Product on Body Weight Regulation in <i>ob</i> / <i>ob</i> Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017 · see citing works
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1714 · Cited by 2,940 · see citing works
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998 · see citing works
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15693 · Cited by 1,359 · see citing works
Self-citationLeptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247 · cited 4× · see citing works
“This hypothesis is supported by the decreases in resting energy expenditure observed with leptin administration in patients with lipodystrophies (15).”
BackgroundInfluentialSelf-citationFarooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215693 · Cited by 1,105 · see citing works
Self-citationLeptin Signaling, Adiposity, and Energy Balance
Jéquier, E. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04293.x · Cited by 789 · see citing works
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 622 · cited 1× · see citing works
“The lipodystrophies are rare disorders that are characterized by selective loss of sc and/or visceral fat due to any of several genetic or acquired conditions that alter the ability to store triglyceride in adipose tissue (1).”
BackgroundSelf-citationHavel, P. J. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00008 · Cited by 575 · see citing works
Barrachina, M. D., Martínez, V., Wang, L., Wei, J. Y., & Taché, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10455 · Cited by 440 · see citing works
Rolls, B. J., Hetherington, M. M., & Burley, V. J. (1988) · Physiology & Behavior · doi:10.1016/0031-9384(88)90230-2 · Cited by 307 · see citing works
Keim, N., Stern, J. S., & Havel, P. J. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.4.794 · Cited by 272 · see citing works
High-fat meals reduce 24-h circulating leptin concentrations in women.
Havel, P. J., Townsend, R. R., Chaump, L., & Teff, K. L. (1999) · Diabetes · doi:10.2337/diabetes.48.2.334 · Cited by 268 · see citing works
Roles of Leptin and Ghrelin in the Loss of Body Weight Caused by a Low Fat, High Carbohydrate Diet
Weigle, D. S., Cummings, D. E., Newby, P. D., Breen, P. A., Frayo, R. S., Matthys, C. C., Callahan, H. S., & Purnell, J. Q. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021262 · Cited by 212 · see citing works
The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans
Matzinger, D., Degen, L., Drewe, J., Meuli, J., Duebendorfer, R., Ruckstuhl, N., D'Amato, M., Rovati, L., & Beglinger, C. (2000) · Gut · doi:10.1136/gut.46.5.689 · Cited by 198 · see citing works
Gastrointestinal correlates of the development of hunger in man
Sepple, C. P., & Read, N. W. (1989) · Appetite · doi:10.1016/0195-6663(89)90011-1 · Cited by 170 · see citing works
(2000) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(00)00428-4 · Cited by 148 · see citing works
Patterns of food selection during meals in women with bulimia
Hadigan, C. M., Kissileff, H. R., & Walsh, B. T. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/50.4.759 · Cited by 145 · see citing works
Brain Pathways Controlling Food Intake and Body Weight
Schwartz, M. W. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122601103 · Cited by 132 · see citing works
Leptin Deficiency Induced by Fasting Impairs the Satiety Response to Cholecystokinin
McMinn, J. E., Sindelar, D. K., Havel, P. J., & Schwartz, M. W. (2000) · Endocrinology · doi:10.1210/endo.141.12.7815 · Cited by 129 · see citing works
Laboratory studies of eating behavior in women with bulimia
Kissileff, H. R., Walsh, B. T., Kral, J. G., & Cassidy, S. M. (1986) · Physiology & Behavior · doi:10.1016/0031-9384(86)90426-9 · Cited by 124 · see citing works
Barazzoni, R., Zanetti, M., Stebel, M., Biolo, G., Cattin, L., & Guarnieri, G. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00281-6 · Cited by 124 · see citing works
Regulation of appetite: role of leptin in signalling systems for drive and satiety
Blundell, J. E., Goodson, S., & Halford, J. C. G. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801693 · Cited by 116 · see citing works
Romon, M., Lebel, P., Velly, C., Marécaux, N., Fruchart, J., & Dallongeville, J. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e855 · Cited by 113 · see citing works
Association of leptin and hunger-satiety ratings in obese women
Af, H., Lara‐Castro, C., Kirk, K. A., Considine, R. V., Caro, J. F., & Weinsier, R. L. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800731 · Cited by 88 · see citing works
Eating behavior in bulimia nervosa: multiple meal analyses
Hetherington, M. M., Altemus, M., Nelson, M., Bernat, A. S., & Gold, P. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.6.864 · Cited by 86 · see citing works
How the brain regulates food intake and body weight: the role of leptin.
Baskin, D. G., Blevins, J. E., & Schwartz, M. W. (2001) · PubMed · Cited by 56 · see citing works
Peters, A. L., & Schriger, D. L. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00206-x · Cited by 31 · see citing works
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Havel, P. J. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00132.x · Cited by 607 · see citing works
Rosenbaum, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25977 · Cited by 575 · see citing works
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
Brown, R. J., Araújo‐Vilar, D., Cheung, P. T., Dunger, D. B., Garg, A., Jack, M., Mungai, L., Oral, E. A., Patni, N., Rother, K. I., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2466 · Cited by 532 · see citing works
Self-citationLeptin receptor action and mechanisms of leptin resistance
Münzberg, H., Björnholm, M., Bates, S. H., & Myers, M. G. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4432-1 · Cited by 261 · see citing works
Congenital generalized lipodystrophies—new insights into metabolic dysfunction
Patni, N., & Garg, A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.123 · Cited by 262 · see citing works
Lipodystrophy: pathophysiology and advances in treatment
Fiorenza, C. G., Chou, S. H.-H., & Mantzoros, C. S. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.199 · Cited by 255 · see citing works
Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy
Javor, E. D., Cochran, E. K., Musso, C., Young, J. R., DePaoli, A. M., & Gorden, P. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1994 · Cited by 226 · see citing works
Self-citationLeptin in Leanness and Obesity
Perakakis, N., Farr, O. M., & Mantzoros, C. S. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.069 · Cited by 218 · see citing works
Diker‐Cohen, T., Cochran, E. K., Görden, P., & Brown, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4491 · Cited by 180 · see citing works
Efficacy of leptin therapy in the different forms of human lipodystrophy
Chong, A. Y., Lupsa, B. C., Cochran, E. K., & Görden, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1502-9 · Cited by 175 · see citing works
Lee, J. H., Chan, J. L., Sourlas, E., Raptopoulos, V., & Mantzoros, C. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1545 · Cited by 163 · see citing works
Clinical Effects of Long-Term Metreleptin Treatment in Patients With Lipodystrophy
Chan, J. L., Lutz, K., Cochran, E. K., Huang, W., Peters, Y., Weyer, C., & Görden, P. (2011) · Endocrine Practice · doi:10.4158/ep11229.or · Cited by 145 · see citing works
Ahima, R. S., & Osei, S. Y. (2008) · Frontiers of hormone research · doi:10.1159/000115365 · Cited by 136 · see citing works
Adipose Tissue: Physiology to Metabolic Dysfunction
Richard, A. J., White, U. A., Elks, C. M., & Stephens, J. M. (2020) · Europe PMC (PubMed Central) · Cited by 118 · see citing works
Role of leptin resistance in the development of obesity in older patients
Picard, F., Carter, S., Caron, A., & Richard, D. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s36367 · Cited by 129 · see citing works
Akıncı, B., Meral, R., & Oral, E. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1099-9 · Cited by 104 · see citing works
Self-citationBrown, R. J., Valencia, A., Startzell, M. S., Cochran, E. K., Walter, P. J., Garraffo, H. M., Cai, H., Gharib, A. M., Ouwerkerk, R., Courville, A. B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95476 · Cited by 100 · see citing works
Metreleptin: First Global Approval
Chou, K., & Perry, C. M. (2013) · Drugs · doi:10.1007/s40265-013-0074-7 · Cited by 99 · see citing works
Simha, V., Subramanyam, L., Szczepaniak, L. S., Quittner, C., ADAMS-HUET, B. A., Snell, P. G., & Garg, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2229 · Cited by 96 · see citing works
Pediatric Obesity: Etiology and Treatment
Crocker, M. K., & Yanovski, J. A. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.06.007 · Cited by 95 · see citing works
Self-citationPerry, R. J., Resch, J. M., Douglass, A. M., Madara, J. C., Rabin-Court, A., Kucukdereli, H., Wu, C., Song, J. D., Lowell, B. B., & Shulman, G. I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901795116 · Cited by 95 · see citing works
Pharmacotherapy for childhood obesity: present and future prospects
Sherafat‐Kazemzadeh, R., Yanovski, S. Z., & Yanovski, J. A. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.144 · Cited by 80 · see citing works
Self-citationFamilial Partial Lipodystrophy (FPLD): Recent Insights
Bagias, C., Xiarchou, A., Bargiota, Α., & Tigas, S. K. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s206053 · Cited by 80 · see citing works
Rationale for Leptin-Replacement Therapy for Severe Lipodystrophy
Oral, E. A., & Chan, J. L. (2010) · Endocrine Practice · doi:10.4158/ep09155.ra · Cited by 77 · see citing works
Self-citationMeehan, C. A., Cochran, E. K., Kassai, A., Brown, R. J., & Görden, P. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1096772 · Cited by 73 · see citing works
Perspective on the Central Control of Appetite
Blundell, J. E. (2006) · Obesity · doi:10.1038/oby.2006.298 · Cited by 72 · see citing works
Neuroendocrine and metabolic effects of adipocyte-derived hormones
Jackson, M. B., & Ahima, R. S. (2006) · Clinical Science · doi:10.1042/cs20050243 · Cited by 68 · see citing works
Inherited lipodystrophies and hypertriglyceridemia.
Simha, V., & Garg, A. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832d4a33 · Cited by 67 · see citing works
Early-life programming of adipose tissue
Moreno‐Méndez, E., Quintero-Fabián, S., Fernández‐Mejía, C., & Lazo-de-la-Vega-Monroy, M.-L. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000037 · Cited by 65 · see citing works
Hebebrand, J., Hildebrandt, T., Schlögl, H., Seitz, J., Denecke, S., Vieira, D. B., Gradl-Dietsch, G., Peters, T., Antel, J., Lau, D., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104807 · Cited by 61 · see citing works
Ping‐Delfos, W. C. S., & Soares, M. J. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2010.11.006 · Cited by 61 · see citing works
Leptin in congenital and HIV-associated lipodystrophy
Tsoukas, M. A., Farr, O. M., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.017 · Cited by 58 · see citing works
Serum leptin and loss of control eating in children and adolescents
Miller, R., Tanofsky‐Kraff, M., Shomaker, L. B., Field, S. E., Hannallah, L. M., Reina, S. A., Mooreville, M., Sedaka, N. M., Brady, S. M., Condarco, T. A., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.126 · Cited by 57 · see citing works
Self-citationClinical Features and Management of Non-HIV–Related Lipodystrophy in Children: A Systematic Review
Gupta, N., Asi, N., Farah, W. H., Almasri, J., Barrionuevo, P., Alsawas, M., Wang, Z., Haymond, M. W., Brown, R. J., & Murad, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2271 · Cited by 57 · see citing works
Sutinen, J., & Yki‐Järvinen, H. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00219.2006 · Cited by 55 · see citing works
Lipodystrophies: adipose tissue disorders with severe metabolic implications
Cortés, V., & Fernández‐Galilea, M. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0404-1 · Cited by 53 · see citing works
Adipokines as Clinically Relevant Therapeutic Targets in Obesity
Würfel, M., Blüher, M., Stümvoll, M., Ebert, T., Kovacs, P. L., Tönjes, A., & Breitfeld, J. (2023) · Biomedicines · doi:10.3390/biomedicines11051427 · Cited by 54 · see citing works
Aotani, D., Ebihara, K., Sawamoto, N., Kusakabe, T., Aizawa‐Abe, M., Yamamoto‐Kataoka, S., Sakai, T., Iogawa, H., Ebihara, C., Fujikura, J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1872 · Cited by 49 · see citing works
Pediatric Obesity: Etiology and Treatment
Crocker, M. K., & Yanovski, J. A. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.07.004 · Cited by 50 · see citing works
Self-citationDiagnostic strategies and clinical management of lipodystrophy
Foss‐Freitas, M. C., Akıncı, B., Luo, Y., Stratton, A., & Oral, E. A. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1735360 · Cited by 51 · see citing works
Self-citationMetreleptin Improves Blood Glucose in Patients With Insulin Receptor Mutations
Brown, R. J., Cochran, E. K., & Görden, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2317 · Cited by 44 · see citing works
The role of obstructive sleep apnea in metabolic syndrome: A population-based study in women
Theorell‐Haglöw, J., Berne, C., Janson, C., & Lindberg, E. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.06.014 · Cited by 44 · see citing works
Özen, S., Akıncı, B., & Oral, E. A. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2019.2019.0124 · Cited by 44 · see citing works
Self-citationNovel strategy for the use of leptin for obesity therapy
Tam, C. S., Lecoultre, V., & Ravussin, É. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.619974 · Cited by 46 · see citing works
Li, Y., Wu, X., Zhou, S.-Y., & Owyang, C. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00356.2010 · Cited by 43 · see citing works
RetractedSleep Duration and Obesity in Adults: What Are the Connections?
Theorell‐Haglöw, J., & Lindberg, E. (2016) · Current Obesity Reports · doi:10.1007/s13679-016-0225-8 · Cited by 43 · see citing works
Sekizkardes, H., Cochran, E. K., Malandrino, N., Garg, A., & Brown, R. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02787 · Cited by 42 · see citing works
Efficacy and Safety of Metreleptin Therapy in Patients With Type 1 Diabetes: A Pilot Study
Vasandani, C., Clark, G. O., ADAMS-HUET, B. A., Quittner, C., & Garg, A. (2017) · Diabetes Care · doi:10.2337/dc16-1553 · Cited by 41 · see citing works
Gradl-Dietsch, G., Milos, G. F., Wabitsch, M., Bell, R., Tschoepe, F., Antel, J., & Hebebrand, J. (2022) · Obesity Facts · doi:10.1159/000527386 · Cited by 40 · see citing works
Update on Therapeutic Options in Lipodystrophy
Akıncı, B., Meral, R., & Oral, E. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1100-7 · Cited by 40 · see citing works
Self-citationSchlögl, H., Müller, K., Horstmann, A., Miehle, K., Püschel, J., Villringer, A., Pleger, B., Stümvoll, M., & Faßhauer, M. (2016) · Diabetes · doi:10.2337/db15-1550 · Cited by 36 · see citing works
Nakao, K., Minato, N., & Üemoto, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55651-0 · Cited by 32 · see citing works
Repositioning leptin as a therapy for Alzheimer’s disease
Johnston, J. M., Greco, S. J., Hamzelou, A., Ashford, J. W., & Tezapsidis, N. (2011) · Therapy · doi:10.2217/thy.11.57 · Cited by 32 · see citing works
An overview of lipodystrophy and the role of the complement system
Corvillo, F., & Akıncı, B. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.05.011 · Cited by 31 · see citing works
Kinzer, A. B., Shamburek, R. D., Lightbourne, M., Muniyappa, R., & Brown, R. J. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00103 · Cited by 30 · see citing works
Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives
Tchang, B. G., Shukla, A. P., & Aronne, L. J. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1052789 · Cited by 28 · see citing works
Investigational therapies in the treatment of obesity
Mancini, M. C., & Halpern, A. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.8.897 · Cited by 28 · see citing works
Metabolic Contributions of Wnt Signaling: More Than Controlling Flight
Azar, F. A., & Lim, G. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.709823 · Cited by 25 · see citing works
Therapeutic use of recombinant methionyl human leptin
Vatier, C., Gautier, J., & Vigouroux, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.03.013 · Cited by 28 · see citing works
LeDuc, C. A., Skowronski, A. A., & ROSENBAUM, M. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.789519 · Cited by 26 · see citing works
Seeking satiety: From signals to solutions
Tschöp, M. H., & Friedman, J. M. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adh4453 · Cited by 24 · see citing works
Aliasghari, F., Yagin, N. L., & Mahdavi, R. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.11.013 · Cited by 25 · see citing works
A rapid action plan to improve diagnosis and management of lipodystrophy syndromes
Fourman, L. T., Lima, J. G., Simha, V., Cappa, M., Al-Yaarubi, S., Montenegro, R. M., Akıncı, B., & Santini, F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1383318 · Cited by 24 · see citing works
A National Multicenter Study of Leptin and Leptin Receptor Deficiency and Systematic Review
Besci, Ö., Fırat, S. N., Özen, S., Çetinkaya, S. Ç., Akın, L., Kör, Y., Pekkolay, Z., Özalkak, Ş., Özsu, E., Erdeve, Ş. S., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad099 · Cited by 21 · see citing works
Self-citationMeral, R., Malandrino, N., Walter, M. F., Neidert, A., Muniyappa, R., Oral, E. A., & Brown, R. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab760 · Cited by 17 · see citing works
Self-citationPüschel, J., Miehle, K., Müller, K., Villringer, A., Stümvoll, M., Faßhauer, M., & Schlögl, H. (2018) · Cytokine · doi:10.1016/j.cyto.2018.10.012 · Cited by 17 · see citing works
Eating disorder symptoms among transgender and gender diverse youth
KRAMER, R. A., Peterson, C. M., Conard, L. A. E., Lenz, K. R., & Matthews, A. L. (2023) · Clinical Child Psychology and Psychiatry · doi:10.1177/13591045231184917 · Cited by 16 · see citing works
Diagnosis and management of lipodystrophy: a practical update
Stears, A. J., & Hames, C. (2014) · Clinical Lipidology · doi:10.2217/clp.14.13 · Cited by 15 · see citing works
Santos, J. L., & Cortés, V. (2020) · Obesity Reviews · doi:10.1111/obr.13114 · Cited by 19 · see citing works
Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated Lipodystrophy
Kralisch, S., Hoffmann, A., Estrada-Kunz, J., Stümvoll, M., Faßhauer, M., Tönjes, A., & Miehle, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197214 · Cited by 15 · see citing works
Lambadiari, V., Kountouri, A., Maratou, E., Liatis, S., Dimitriadis, G., & Karpe, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.684182 · Cited by 14 · see citing works
Metreleptin for metabolic disorders associated with generalized or partial lipodystrophy
Simha, V. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.894877 · Cited by 14 · see citing works
GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy
Roumane, A., Mcilroy, G. D., Sommer, N., Han, W., Heisler, L. K., & Rochford, J. J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1379228 · Cited by 13 · see citing works
Sarmento, A. S. C., Lima, J. G., Timóteo, A. R. D. S., Ururahy, M. A. G., de Araújo, A. A., Vasconcelos, R. C., Dantas, V. K. C., Agnez‐Lima, L. F., & Campos, J. T. A. D. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158610 · Cited by 12 · see citing works
Adamski, K., Cook, K., Gupta, D., Morris, E., Tuttle, E., Carr, E., Cremasco, F., Cochran, E., & Brown, R. J. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1976125 · Cited by 11 · see citing works
Lightbourne, M., Wolska, A. T., Abel, B. S., Rother, K. I., Walter, M. F., Kushchayeva, Y. S., Auh, S., Shamburek, R. D., Remaley, A. T., Muniyappa, R., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa191 · Cited by 11 · see citing works
Casey, S., Lokan, J., Testro, A., Farquharson, S., Connelly, A., Proietto, J., & Angus, P. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12436 · Cited by 10 · see citing works
Treatment Options for Lipodystrophy in Children
Mainieri, F., Tagi, V. M., & Chiarelli, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.879979 · Cited by 10 · see citing works
Tsoukas, M. A., & Mantzoros, C. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00037-8 · Cited by 10 · see citing works
Leptin and Appetite Control in Lipodystrophy
Ahima, R. S., & Osei, S. Y. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1232 · Cited by 10 · see citing works
Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?
Meral, R., Güler, M. Ç., Kaba, D., Prativadi, J., Frontera, E. D., Foss‐Freitas, M. C., Nachawi, N., Broome, D. T., Lightbourne, M., Brown, R. J., et al. (2025) · Diabetes Care · doi:10.2337/dc24-2408 · Cited by 9 · see citing works
Self-citationAdipokines and etiopathology of metabolic disorders
AL-Dokhi, L. M. (2009) · Saudi Medical Journal · doi:10.15537/1658-3175.4817 · Cited by 9 · see citing works
Clinical Guidance for Lipodystrophy Syndromes: From Diagnosis and Work-Up to Treatment
Gilio, D., Foss‐Freitas, M. C., & Oral, E. A. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01603-4 · Cited by 11 · see citing works
Self-citationTranslational Research of Leptin in Lipodystrophy and Its Related Diseases
Ebihara, K., & Nakao, K. (2015) · Springer eBooks · doi:10.1007/978-4-431-55651-0_14 · Cited by 8 · see citing works
Zhang, Y., & Ren, J. T. (2015) · Springer eBooks · doi:10.1007/978-3-319-19821-7_4 · Cited by 8 · see citing works
Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy
Beghini, M., Metz, M., Baumgartner, C., Wolf, P. S., Bastian, M., Hackl, M. T., Baumgartner-Parzer, S. M., Marculescu, R., Krebs, M., Harreiter, J., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156261 · Cited by 7 · see citing works
Metreleptin treatment of non-HIV lipodystrophy syndromes
Chevalier, B., Lemaître, M., Leguier, L., Mapihan, K. L., Douillard, C., Jannin, A., Espiard, S., & Vantyghem, M. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104070 · Cited by 8 · see citing works
Martin, S. A., Sanchez, R. J., Olayinka-Amao, O., Harris, C. A., & Fehnel, S. E. (2022) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-022-00486-3 · Cited by 6 · see citing works
Ambivalent Food Craving and Psychobiological Characteristics in Individuals With Weight Suppression
Lee, M., & Lee, J.-H. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.619025 · Cited by 6 · see citing works
Iwanishi, M., Ebihara, K., Kusakabe, T., Washiyama, M., Ito‐Kobayashi, J., Nakamura, F., Togawa, T., Ozamoto, Y., Hagiwara, A., & Nakao, K. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1713 · Cited by 6 · see citing works
Metreleptin in lipodystrophy: a profile of its use
Deeks, E. D. (2019) · Drugs & Therapy Perspectives · doi:10.1007/s40267-019-00622-y · Cited by 6 · see citing works
Conroy, R., Febres, G., McMahon, D. J., Thorner, M. O., Gaylinn, B. D., Conwell, I. M., Aronne, L. J., & Körner, J. (2014) · International Journal of Endocrinology · doi:10.1155/2014/120286 · Cited by 5 · see citing works
Miehle, K., von Schnurbein, J., Faßhauer, M., Stümvoll, M., Borck, G., & Wabitsch, M. (2017) · Medizinische Genetik · doi:10.1007/s11825-017-0162-2 · Cited by 3 · see citing works
Adamowski, M., Sharma, Y., Molcan, T., Wołodko, K., Kelsey, G., & Galvão, A. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-58181-w · Cited by 5 · see citing works
Palazzo, R. P., Torres, I. L. D. S., Grefenhagen, Á. I. D. S., da Silva, B. B., de Meireles, L. C. F., de Vargas, K. C., Alves, Z. D. S., Pereira, L. O., & Siqueira, I. R. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10063 · Cited by 5 · see citing works
Schlögl, H., Villringer, A., Miehle, K., Faßhauer, M., Stümvoll, M., & Mueller, K. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad072 · Cited by 4 · see citing works
Gao, C., & Mantzoros, C. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00038-1 · Cited by 4 · see citing works
Brown, R. J., Akıncı, B., Al-Yaarubi, S., Bismuth, É., Cappa, M., Deeb, A., Kamrath, C., Musso, C., Patni, N., Prodam, F., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1597053 · Cited by 3 · see citing works
Altered acylated ghrelin response to food intake in congenital generalized lipodystrophy
de Araújo, C. O. D., Montenegro, R. M., Pedroso, A. P., Fernandes, V. O., Montenegro, A. P. D. R., de Carvalho, A. B., Oyama, L. M., Maia, C. S. C., & Ribeiro, E. B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244667 · Cited by 3 · see citing works
Besci, Ö., Güler, M. Ç., Foss‐Freitas, M. C., & Oral, E. A. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2574318 · Cited by 2 · see citing works
Self-citation
- Authors
- McDuffie, J. R., Riggs, P. A., Calis, K. A., Freedman, R. J., Oral, E. A., DePaoli, A. M., & Yanovski, J. A.
- Affiliations
- National Institutes of Health (US)
- Nutrition Department (P.A.R.), Maryland 20892
- Drug Information Service, Pharmacy Department (K.A.C.), Warren Grant Magnuson Clinical Center
- Unit on Growth and Obesity, National Institute of Child Health and Human Development (J.R.M., R.J.F., J.A.Y.), Maryland 20892
- Amgen (United States) (US)
- Corresponding author
- Yanovski, Jack A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-09-01
- Volume
- 89
- Issue
- 9
- Pages
- 4258-4263
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2266890
- OpenAlex
- W2150678858
- Cited by
- 129
- References
- 31
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 9 · 2020: 12 · 2019: 6 · 2018: 7 · 2017: 3 · 2016: 4 · 2015: 10 · 2014: 6 · 2013: 5 · 2012: 4
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health and Human Services
- Amgen
- National Institutes of Health (Z99HD999999)
- U.S. Public Health Service
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-54387, R01DK054387)
- National Institute of Child Health and Human Development
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZO1 HD00641, Z01HD000641)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- leptin, lipodystrophy, hypoleptinemia, satiety, satiation, appetite regulation, ghrelin, recombinant human leptin, meal duration, energy intake
- MeSH terms
- Adolescent, Adult, Energy Metabolism, Female, Humans, Lipodystrophy, Satiation, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
